Attività
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Joseph Hagan
CEO | Chief Executive Officer | 55 | 04/01/16 |
Preston Klassen
PSD | President | 55 | 22/06/23 |
Crispina Calsada
DFI | Director of Finance/CFO | 54 | 30/08/19 |
Chief Tech/Sci/R&D Officer | - | 29/11/22 | |
Rekha Garg
LAW | General Counsel | - | 29/11/22 |
Amin Kamel
PRN | Corporate Officer/Principal | - | 02/06/22 |
Daniel Penksa
AUD | Comptroller/Controller/Auditor | 39 | 01/06/15 |
Christopher Aker
LAW | General Counsel | 63 | 19/05/11 |
Brian K. Campion
PRN | Corporate Officer/Principal | - | 01/07/20 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Pascale Witz
BRD | Director/Board Member | 57 | 01/06/17 |
David Baltimore
BRD | Director/Board Member | 86 | 01/01/09 |
Director/Board Member | 75 | 01/04/13 | |
Chairman | 75 | 01/01/08 | |
Jake Nunn
BRD | Director/Board Member | 54 | 11/06/19 |
Alice S. Huang
BRD | Director/Board Member | 85 | 26/01/21 |
Hugh Rosen
BRD | Director/Board Member | 64 | 02/06/16 |
Joseph Hagan
CEO | Chief Executive Officer | 55 | 04/01/16 |
Preston Klassen
PSD | President | 55 | 22/06/23 |
Director/Board Member | 56 | 17/04/18 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 0 | 3 725 720 | 0 | 0 | 95,99 % |
Azione B | 0 | 258 707 | 0 | 0 | |
Azione C | 0 | 1 330 832 | 0 | 0 | |
Azione D | 1 | 65 465 251 | 64 363 054 ( 98,32 %) | 0 | |
Azione E | 0 | 256 700 | 0 | 0 |
Coordinate società
Regulus Therapeutics, Inc.
4224 Campus Point Court Suite 210
92121, San Diego
+858 202 6300
http://www.regulusrx.comSettore
Variaz. 1 gen. | Capi. | |
---|---|---|
+10,44% | 107 Mrd | |
+0,82% | 106 Mrd | |
+8,09% | 23,47 Mrd | |
-13,89% | 21,9 Mrd | |
-5,94% | 18,77 Mrd | |
-37,26% | 17,85 Mrd | |
-10,98% | 16,78 Mrd | |
+8,67% | 14,41 Mrd | |
+41,08% | 12,86 Mrd |